Title:
第ＩＸ因子融合タンパク質及びそれらの製造方法及び使用方法
Document Type and Number:
Japanese Patent JP7418519
Kind Code:
B2
Abstract:
The present invention provides Factor IX (FIX) fusion proteins comprising at least one heterologous moiety, such as an XTEN. The present invention further discloses methods of making and using the FIX fusion proteins.
More Like This:
| WO/2006/059105 | NON-CYTOTOXIC PROTEIN CONJUGATES |
| JP2023164704 | ANTI MUC1 ANTIBODY, AND FUSION PROTEIN CONSTRUCT INCLUDING IL-15 |
| JP2019517773 | Anti-LAG-3 antibody |
Inventors:
Zhizen Liu
Arjan Van Der Flyer
David Earl Wright
Ectus Chabra
Tonyaoriu
Robert T. Peters
John Kulman
Ayman Ismail
Arjan Van Der Flyer
David Earl Wright
Ectus Chabra
Tonyaoriu
Robert T. Peters
John Kulman
Ayman Ismail
Application Number:
JP2022145321A
Publication Date:
January 19, 2024
Filing Date:
September 13, 2022
Export Citation:
Assignee:
Bioverativ Therapeutics Incorporated
International Classes:
C12N15/62; A61K38/36; A61P7/04; C07K14/745; C07K16/00; C07K19/00; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/12; C12N15/13; C12N15/63
Domestic Patent References:
| JP2013502459A | ||||
| JP2013534426A |
Other References:
Chung-Yang Kao et.al.,Thromb Haemost,2013年,110,pp.244-256
Attorney, Agent or Firm:
Shusaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Previous Patent: Position detection device and sensor panel
Next Patent: conductor connection terminal
Next Patent: conductor connection terminal